How Eden and Hims & Hers Differ in GLP-1 Care: A Personalized Experience Breakdown
Compare Eden and Hims & Hers for GLP-1 care. Explore how personalization, licensed provider access, and pharmacy coordination differ.
Learn why GLP-1 meds like semaglutide may cause dry mouth and how to manage it with hydration, oral care, and lifestyle strategies.
Dry mouth, or xerostomia, is an occasionally reported side effect of GLP-1 receptor agonists like semaglutide. While not among the most common reactions, it can impact comfort, eating, and oral health if left unaddressed.
GLP-1 receptor agonists work by regulating blood sugar, slowing digestion, and decreasing appetite. These shifts may temporarily influence hydration and saliva production, particularly in the first month of use or during dose changes.
Dry mouth symptoms are usually mild and temporary, though ongoing dryness should be discussed with your healthcare provider.
Sipping water throughout the day can help support saliva flow and reduce oral dryness.
Tips:
Maintaining a healthy oral environment can minimize discomfort and prevent secondary issues like cavities or gum irritation.
Suggestions:
Encouraging your body’s saliva production can relieve dryness, especially between meals or at night.
Try:
Environmental dryness and common habits can worsen symptoms. Small changes can make a big difference.
Recommendations:
{{primary-cta}}
If dry mouth becomes persistent or disrupts daily routines such as eating, speaking, or sleeping, reach out to your provider. They may:
{{primary-cta}}
Dry mouth is one of several possible side effects, particularly early in treatment. Others may include:
Less common but serious risks include gallbladder symptoms, pancreatitis, or kidney issues. Any new or severe symptom should be reported promptly.
Dry mouth may occur with GLP-1 treatment, especially during the initial weeks, but many individuals are able to manage symptoms through hydration, oral care, and lifestyle adjustments. Any persistent symptoms should be discussed with a licensed provider to determine the best approach.
Eden connects individuals with licensed providers who prescribe FDA-approved GLP-1 medications when clinically appropriate, and who provide ongoing check-ins to help ensure care remains aligned with each patient’s personal goals.
This content is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting, stopping, or changing any medication. Eden provides only FDA-approved GLP-1 therapies under licensed clinical supervision.
Disclaimer: The FDA does not approve compounded medications for safety, quality, or manufacturing. Prescriptions and a medical evaluation are required for certain products. The information provided on this blog is for general informational purposes only. It is not intended as a substitute for professional advice from a qualified healthcare professional and should not be relied upon as personal health advice. The information contained in this blog is not meant to diagnose, treat, cure, or prevent any disease. Readers are advised to consult with a qualified healthcare professional for any medical concerns, including side effects. Use of this blog's information is at your own risk. The blog owner is not responsible for any adverse effects or consequences resulting from the use of any suggestions or information provided in this blog.
It is less common than gastrointestinal symptoms but may occur in some users during dose adjustments.
In many cases, yes. If not, symptom relief strategies or provider adjustments can help.
Not without speaking to your provider. Most cases are mild and manageable with supportive care.
Yes. Reduced saliva can increase risk for tooth decay or gum problems. Regular dental care is recommended during GLP-1 use.